results of a joint study conducted by an international team of scientists from the UK, France, Canada and Denmark, suggest that diabetes and high blood sugar levels may be associated with dysfunction of the gene involved in the regulation of the body's daily rhythms.As informs on the pages an Internet resource medportal.ru, said the discovery could contribute to the emergence of fundamentally new methods of treatment of this widespread disease.
According to data obtained as a result of numerous statistical studies of such diseases as diabetes, obesity, and many cardiovascular diseases, are often associated with various sleep disorders.In addition, according to experts, the hormone insulin deficiency is associated with diabetes, it is capable of being produced in different amounts depending on the different times of day.A new study, which is in question here, allow to come to a conclusion about the genetic nature of the relationship that exists between all these disorders.
In its work international team
analyzed the genomes of a fairly large group of volunteers, the researchers concluded that the mutation rs1387153 shows a statistically significant correlation with increased levels of glucose in the blood.The next phase of the research was the fact that they estimated the frequency of these mutations in 6 thousand residents of France and Denmark, diabetes of the second type, comparing the obtained data with 9000 healthy residents of these states.
The results showed that people with diabetes, this mutation occurs much more frequently, and its presence was associated with a 20 percent increased risk of developing diabetes type 2.
The authors believe that the ever-growing data about the genetic causes of diabetes development, allow to expect the emergence of reliable genetic tests that would identify people with increased susceptibility to these diseases.In addition, as mentioned above, the availability of data on the relationship between diabetes dysregulation of circadian rhythms gives hope for the future emergence of fundamentally new treatments for this very common disease.